BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 31370792)

  • 1. AgeWell.de - study protocol of a pragmatic multi-center cluster-randomized controlled prevention trial against cognitive decline in older primary care patients.
    Zülke A; Luck T; Pabst A; Hoffmann W; Thyrian JR; Gensichen J; Kaduszkiewicz H; König HH; Haefeli WE; Czock D; Wiese B; Frese T; Röhr S; Riedel-Heller SG
    BMC Geriatr; 2019 Aug; 19(1):203. PubMed ID: 31370792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recruitment and Baseline Characteristics of Participants in the AgeWell.de Study-A Pragmatic Cluster-Randomized Controlled Lifestyle Trial against Cognitive Decline.
    Röhr S; Zülke A; Luppa M; Brettschneider C; Weißenborn M; Kühne F; Zöllinger I; Samos FZ; Bauer A; Döhring J; Krebs-Hein K; Oey A; Czock D; Frese T; Gensichen J; Haefeli WE; Hoffmann W; Kaduszkiewicz H; König HH; Thyrian JR; Wiese B; Riedel-Heller SG
    Int J Environ Res Public Health; 2021 Jan; 18(2):. PubMed ID: 33430189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multidomain intervention against cognitive decline in an at-risk-population in Germany: Results from the cluster-randomized AgeWell.de trial.
    Zülke AE; Pabst A; Luppa M; Roehr S; Seidling H; Oey A; Cardona MI; Blotenberg I; Bauer A; Weise S; Zöllinger I; Sanftenberg L; Brettschneider C; Döhring J; Lunden L; Czock D; Haefeli WE; Wiese B; Hoffmann W; Frese T; Gensichen J; König HH; Kaduszkiewicz H; Thyrian JR; Riedel-Heller SG
    Alzheimers Dement; 2024 Jan; 20(1):615-628. PubMed ID: 37768074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to a lifestyle intervention - just a question of self-efficacy? Analysis of the AgeWell.de-intervention against cognitive decline.
    Wittmann FG; Pabst A; Zülke A; Luppa M; Oey A; Boekholt M; Weise S; Fankhänel T; Kosilek RP; Brettschneider C; Döhring J; Lunden L; Wiese B; Hoffmann W; Frese T; Gensichen J; König HH; Kaduszkiewicz H; Thyrian JR; Riedel-Heller SG
    Alzheimers Res Ther; 2024 Jun; 16(1):133. PubMed ID: 38909256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SINgapore GERiatric Intervention Study to Reduce Cognitive Decline and Physical Frailty (SINGER): Study Design and Protocol.
    Xu X; Chew KA; Wong ZX; Phua AKS; Chong EJY; Teo CKL; Sathe N; Chooi YC; Chia WPF; Henry CJ; Chew E; Wang M; Maier AB; Kandiah N; Chen CL
    J Prev Alzheimers Dis; 2022; 9(1):40-48. PubMed ID: 35098972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Who Benefited the Most? Effectiveness of a Lifestyle Intervention Against Cognitive Decline in Older Women and Men - Secondary Analysis of the AgeWell.de-trial.
    Wittmann FG; Pabst A; Zülke A; Luppa M; Blotenberg I; Cardona MI; Bauer A; Fuchs S; Zöllinger I; Sanftenberg L; Brettschneider C; Döhring J; Lunden L; Czock D; Wiese B; Thyrian JR; Hoffmann W; Frese T; Gensichen J; König HH; Kaduszkiewicz H; Riedel-Heller SG
    J Prev Alzheimers Dis; 2024; 11(2):348-355. PubMed ID: 38374741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body, Brain, Life for Cognitive Decline (BBL-CD): protocol for a multidomain dementia risk reduction randomized controlled trial for subjective cognitive decline and mild cognitive impairment.
    McMaster M; Kim S; Clare L; Torres SJ; D'Este C; Anstey KJ
    Clin Interv Aging; 2018; 13():2397-2406. PubMed ID: 30538436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collaborative treatment of late-life depression in primary care (GermanIMPACT): study protocol of a cluster-randomized controlled trial.
    Wernher I; Bjerregaard F; Tinsel I; Bleich C; Boczor S; Kloppe T; Scherer M; Härter M; Niebling W; König HH; Hüll M
    Trials; 2014 Sep; 15():351. PubMed ID: 25195020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multidomain lifestyle intervention to maintain optimal cognitive functioning in Dutch older adults-study design and baseline characteristics of the FINGER-NL randomized controlled trial.
    Deckers K; Zwan MD; Soons LM; Waterink L; Beers S; van Houdt S; Stiensma B; Kwant JZ; Wimmers SCPM; Heutz RAM; Claassen JAHR; Oosterman JM; de Heus RAA; van de Rest O; Vermeiren Y; Voshaar RCO; Smidt N; Broersen LM; Sikkes SAM; Aarts E; ; ; Köhler S; van der Flier WM
    Alzheimers Res Ther; 2024 Jun; 16(1):126. PubMed ID: 38872204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individualized counselling for active aging: protocol of a single-blinded, randomized controlled trial among older people (the AGNES intervention study).
    Rantanen T; Pynnönen K; Saajanaho M; Siltanen S; Karavirta L; Kokko K; Karvonen A; Kauppinen M; Rantalainen T; Rantakokko M; Portegijs E; Hassandra M
    BMC Geriatr; 2019 Jan; 19(1):5. PubMed ID: 30616537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Multi-domain Lifestyle Intervention for Cognitive Impairment in Community-Dwelling Older Adults in Hangzhou (The Heritage Study): Study Design and Protocol.
    Xu X; Pang T; Zhou Y; Zhang H; Ma A; Yuan C; Chen H; Wen X; Yang Q; Xu X
    J Prev Alzheimers Dis; 2024; 11(3):601-611. PubMed ID: 38706276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary dementia care based on the individual needs of the patient: study protocol of the cluster randomized controlled trial, DemStepCare.
    Bablok I; Binder H; Stelzer D; Kaier K; Graf E; Wangler J; Jansky M; Löhr M; Schulz M; Kockläuner M; Geschke K; Wuttke-Linnemann A; Fellgiebel A; Farin E;
    BMC Geriatr; 2021 Apr; 21(1):222. PubMed ID: 33794789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Japan-Multimodal Intervention Trial for Prevention of Dementia (J-MINT): The Study Protocol for an 18-Month, Multicenter, Randomized, Controlled Trial.
    Sugimoto T; Sakurai T; Akatsu H; Doi T; Fujiwara Y; Hirakawa A; Kinoshita F; Kuzuya M; Lee S; Matsuo K; Michikawa M; Ogawa S; Otsuka R; Sato K; Shimada H; Suzuki H; Suzuki H; Takechi H; Takeda S; Umegaki H; Wakayama S; Arai H
    J Prev Alzheimers Dis; 2021; 8(4):465-476. PubMed ID: 34585222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicomponent integrative intervention to slow down the progression of mild cognitive impairment: A protocol for a randomized controlled trial.
    Lyu Q; Cheung DSK; Lai H; Wang X; Qiu J; Huang Y; Zeng Y
    Res Nurs Health; 2020 Aug; 43(4):307-316. PubMed ID: 32627231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multifactorial interdisciplinary intervention to prevent functional and mobility decline for more participation in (pre-)frail community-dwelling older adults (PromeTheus): study protocol for a multicenter randomized controlled trial.
    Werner C; Wolf-Belala N; Nerz C; Abel B; Braun T; Grüneberg C; Thiel C; Büchele G; Muche R; Hendlmeier I; Schäufele M; Dams J; König HH; Bauer JM; Denkinger M; Rapp K
    BMC Geriatr; 2022 Feb; 22(1):124. PubMed ID: 35164686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintain Your Brain: Protocol of a 3-Year Randomized Controlled Trial of a Personalized Multi-Modal Digital Health Intervention to Prevent Cognitive Decline Among Community Dwelling 55 to 77 Year Olds.
    Heffernan M; Andrews G; Fiatarone Singh MA; Valenzuela M; Anstey KJ; Maeder AJ; McNeil J; Jorm L; Lautenschlager NT; Sachdev PS; Ginige JA; Hobbs MJ; Boulamatsis C; Chau T; Cobiac L; Cox KL; Daniel K; Flood VM; Guerrero Y; Gunn J; Jain N; Kochan NA; Lampit A; Mavros Y; Meiklejohn J; Noble Y; O'Leary F; Radd-Vagenas S; Walton CC; ; Brodaty H
    J Alzheimers Dis; 2019; 70(s1):S221-S237. PubMed ID: 30475762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating a multimodal lifestyle intervention with medical food in prodromal Alzheimer's disease: the MIND-AD
    Thunborg C; Wang R; Rosenberg A; Sindi S; Andersen P; Andrieu S; Broersen LM; Coley N; Couderc C; Duval CZ; Faxen-Irving G; Hagman G; Hallikainen M; Håkansson K; Kekkonen E; Lehtisalo J; Levak N; Mangialasche F; Pantel J; Rydström A; Stigsdotter-Neely A; Wimo A; Ngandu T; Soininen H; Hartmann T; Solomon A; Kivipelto M
    Alzheimers Res Ther; 2024 May; 16(1):118. PubMed ID: 38812047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.